Evidence map›Paper›PMID 27708578›Full record

ArticleFrontiers in pharmacology2016

Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice.

Lonneke Timmers, Christel C L M Boons, Dirk Mangnus, Peter M Van de Ven, Pieter H Van den Berg, Aart Beeker, Eleonora L Swart, Richard J Honeywell, Godefridus J Peters, Epie Boven and 1 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Observational
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The association between patients' perceived continuity of care and beliefs about oral anticancer treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lonneke TimmersDepartment of Clinical Pharmacology and Pharmacy, VU University Medical Center Amsterdam, Netherlands.
Christel C L M BoonsDepartment of Clinical Pharmacology and Pharmacy, VU University Medical Center Amsterdam, Netherlands.
Dirk MangnusDepartment of Pharmacy, Slingeland Ziekenhuis Doetinchem, Netherlands.
Peter M Van de VenDepartment of Epidemiology and Biostatistics, VU University Medical Center Amsterdam, Netherlands.
Pieter H Van den BergDepartment of Internal Medicine, Tergooi Hospital Hilversum, Netherlands.
Aart BeekerDepartment of Internal Medicine, Spaarne Hospital Hoofddorp, Netherlands.
Eleonora L SwartDepartment of Clinical Pharmacology and Pharmacy, VU University Medical Center Amsterdam, Netherlands.
Richard J HoneywellDepartment of Medical Oncology, VU University Medical Center Amsterdam, Netherlands.
Godefridus J PetersDepartment of Medical Oncology, VU University Medical Center Amsterdam, Netherlands.
Epie BovenDepartment of Medical Oncology, VU University Medical Center Amsterdam, Netherlands.
Jacqueline G HugtenburgDepartment of Clinical Pharmacology and Pharmacy, VU University Medical CenterAmsterdam, Netherlands; The EMGO Institute for Health and Care Research, VU University Medical CenterAmsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

capecitabinedose adjustmentsmedication adherenceoral anticancer agentpatient-reported symptomspharmacokinetics

Identifiers

PMID27708578
PMCPMC5030243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.